In vivo metabolism and reaction with dna of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC)
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (19) , 3243-3247
- https://doi.org/10.1016/0006-2952(86)90419-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- 1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogs of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC)Journal of Medicinal Chemistry, 1984
- In vitro mutagenic activity of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in eukaryotic and prokaryotic cellsCarcinogenesis: Integrative Cancer Research, 1982
- Preferential methylation of target organ DNA by the oesophageal carcinogen N-nitrosomethylbenzylamineCarcinogenesis: Integrative Cancer Research, 1980
- An efficient and convenient synthesis of 5-(3,3-dimethyl-14C-1-triazeno)-imidazole-4-carboxamideJournal of Labelled Compounds and Radiopharmaceuticals, 1979
- ALKYLATION OF RAT BRAIN NUCLEIC ACIDS BY N‐METHYL‐N‐NITROSOUREA AND METHYL METHANESULPHONATEJournal of Neurochemistry, 1973
- Chemotherapy of malignant melanomaCancer, 1972
- 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanomaPublished by Elsevier ,1972
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanomaClinical Pharmacology & Therapeutics, 1971
- Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-Dimethyl-1-triazeno)-imidazole 5(4)-carboxomideToxicology and Applied Pharmacology, 1971
- Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitroBiochemical Pharmacology, 1969